Geode Capital Management
OKUR

Geode Capital Management’s OnKure Therapeutics OKUR Stock Holding History

Geode Capital Management’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.3M Buy
724,438
+625,688
+634% +$2.68M ﹤0.01% 3075
2026
Q1 		$409K Buy
98,750
+21,281
+27% +$65.7K ﹤0.01% 3656
2025
Q4 		$225K Sell
77,469
-7,426
-9% -$22.2K ﹤0.01% 3862
2025
Q3 		$233K Hold
84,895
– – ﹤0.01% 3872
2025
Q2 		$203K Sell
84,895
-1,416
-2% -$3.71K ﹤0.01% 3865
2025
Q1 		$371K Buy
86,311
+9,712
+13% +$54.6K ﹤0.01% 3652
2024
Q4 		$659K Buy
76,599
+55,149
+257% +$835K ﹤0.01% 3517
2024
Q3 		$365K Buy
21,450
+1,346
+7% +$19.9K ﹤0.01% 3702
2024
Q2 		$304K Sell
20,104
-13,166
-40% -$223K ﹤0.01% 3761
2024
Q1 		$552K Sell
33,270
-684
-2% -$11.3K ﹤0.01% 3574
2023
Q4 		$543K Buy
33,954
+891
+3% +$55.5K ﹤0.01% 3581
2023
Q3 		$2.52M Buy
33,063
+3,617
+12% +$246K ﹤0.01% 2989
2023
Q2 		$1.93M Buy
29,446
+19,785
+205% +$1.59M ﹤0.01% 3125
2023
Q1 		$578K Buy
9,661
+830
+9% +$30.1K ﹤0.01% 3586
2022
Q4 		$205K Sell
8,831
-19
-0.2% -$504 ﹤0.01% 4082
2022
Q3 		$296K Buy
8,850
+3,514
+66% +$115K ﹤0.01% 3997
2022
Q2 		$141K Sell
5,336
-6,780
-56% -$158K ﹤0.01% 4438
2022
Q1 		$356K Buy
12,116
+192
+2% +$10.7K ﹤0.01% 4115
2021
Q4 		$1.02M Sell
11,924
-143
-1% -$10.5K ﹤0.01% 3714
2021
Q3 		$898K Buy
12,067
+4,860
+67% +$412K ﹤0.01% 3737
2021
Q2 		$672K Buy
+7,207
New +$804K ﹤0.01% 3796

Other funds holding OKUR

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
SG
StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management's OKUR Position: Q2 2026 in Review

Geode Capital Management increased its OnKure Therapeutics (OKUR) stake by 634% in Q2 2026, buying an estimated $2.68M and bringing the position to 724,438 shares worth $3.3M. The position accounts for ﹤0.01% of the portfolio, ranked #3075.

Geode Capital Management first reported a position in OKUR in Q2 2021 and has held it in 21 quarters since. 75 funds tracked by Wall St. Rank hold OKUR as of Q2 2026.

  • Geode Capital Management held 724,438 shares of OnKure Therapeutics worth $3.3M as of Q2 2026.
  • Geode Capital Management bought 625,688 OnKure Therapeutics shares in Q2 2026, an estimated $2.68M.
  • OnKure Therapeutics made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3075 holding.
  • Geode Capital Management first reported a position in OnKure Therapeutics in Q2 2021 and has held it in 21 quarters since.
  • 75 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.